CPG Co-Manufacturing Agreements: Who Owns the Formula, Process, and Manufacturing Know-How?

A CPG brand may own its trademark, packaging, and even its formula without owning all of the know-how required to manufacture the product somewhere else. Understanding the difference between manufacturing, formulation, and development services is critical to protecting portability and long-term brand value.

---

CPG brands: before signing a co-manufacturing agreement, make sure you know what you are actually buying.

Are you hiring a manufacturer to produce a product using a formula and process you already own? Or are you asking that manufacturer to help formulate the product, develop the commercial manufacturing process, determine production sequencing, establish specifications, solve scale-up problems, or otherwise create the know-how necessary to make the product work?

Those are different relationships. And that distinction can determine who owns some of the most valuable intellectual property in the business.

A brand may own its name, trademarks, packaging, and even the product formula while still discovering that the co-manufacturer owns—or at least claims rights in—the manufacturing process or know-how necessary to reproduce the product at another facility.

That usually becomes a much bigger issue when the brand wants to change manufacturers, raise capital, bring on a strategic partner, or sell the company.

The better approach is to address ownership, access, use rights, and portability at the beginning of the relationship.

1. A Formula and a Manufacturing Process Are Not Necessarily the Same Thing

When CPG founders think about intellectual property, the formula often gets most of the attention. But knowing what goes into a product is not always the same as knowing how to manufacture it successfully at commercial scale.

Depending on the product, the commercially valuable know-how may include:

• ingredient order and sequencing;

• mixing times and speeds;

• temperatures and pressure;

• equipment settings;

• processing tolerances;

• hold times;

• filling or packaging procedures;

• testing protocols;

• quality specifications;

• sourcing requirements;

• scale-up adjustments; and

• troubleshooting methods developed through production experience.

  
  

For a relatively simple product, the formula and ordinary manufacturing instructions may be enough. For a more technically sensitive food, beverage, supplement, beauty, personal-care, household, or other consumer product, the manufacturing process itself may represent meaningful value.

That creates the first question every CPG brand should understand: Who developed the process?

2. Brand-Owned Process vs. Co-Manufacturer Know-How

If the brand arrives with a completed formula, detailed manufacturing process, specifications, and established SOPs, the intellectual-property analysis may be relatively straightforward: the co-manufacturer is being hired primarily to execute the brand’s process.

In that scenario, the agreement should make clear that the brand retains ownership of its pre-existing intellectual property and that the co-manufacturer receives only the rights necessary to manufacture the product for the brand.

The harder situation arises when the co-manufacturer is doing more than executing instructions.

Maybe the brand has a kitchen-scale formula but the co-manufacturer figures out how to produce it in 5,000-gallon batches. Maybe the manufacturer changes ingredient sequencing to prevent separation. Maybe it determines the correct temperatures, dwell times, equipment settings, preservatives, testing protocols, or production tolerances. Maybe the brand simply provides a product concept and desired specifications, while the manufacturer handles much of the technical development.

At that point, the brand may be receiving both manufacturing services and development services, and the parties should not assume those services create the same ownership result.

3. Asking for an SOP Can Mean Two Very Different Things

A common question is whether a CPG brand should be entitled to a written, step-by-step description of how its co-manufacturer produces the product.

Sometimes the answer is straightforward. If the brand owns the formula and manufacturing process and wants documentation confirming that the co-manufacturer is following the required procedures, access to relevant SOPs, batch records, specifications, testing results, and quality documentation can be an important part of verifying performance.

That is fundamentally different from asking: “Tell us exactly how you figured out how to manufacture this product so we can own that knowledge freely (and potentially give your process to another facility).”

If the co-manufacturer independently developed the manufacturing method using its own experience, systems, techniques, or other proprietary know-how, a request for a fully transferable step-by-step process may effectively be a request for the manufacturer’s intellectual property.

A sophisticated co-manufacturer may (should) reject that request.

Or it may agree to provide the information only with:

• additional compensation;

• a specific license;

• confidentiality protections;

• restrictions on disclosure;

• restrictions on use at competing facilities;

• limitations on transfer; or

• other protections around its proprietary know-how.

  
  

The important point is that quality oversight and technology transfer are not necessarily the same thing.

4. A Co-Manufacturing Agreement Is Not Always a Development Agreement

This distinction is easy to miss because multiple business relationships often get collapsed into one document.

A traditional co-manufacturing or contract manufacturing agreement may focus primarily on the commercial production relationship, including:

• product specifications;

• forecasts and purchase orders;

• minimum order quantities;

• pricing;

• raw materials;

• packaging;

• production schedules;

• quality standards;

• testing;

• regulatory responsibilities;

• recalls;

• insurance;

• warranties;

• indemnification;

• confidentiality; and

• termination.

  
  

But if the manufacturer is also helping create the product or the process, additional development terms may be necessary. Depending on the relationship, that could be addressed through:

• a separate formulation agreement;

• a product-development agreement;

• an R&D agreement;

• a technology-development agreement;

• an IP assignment or license; or

• a dedicated development and intellectual-property section within the broader manufacturing agreement.

  
  

The label on the agreement matters less than whether the contract accurately reflects what the parties are actually doing. If one party is creating valuable intellectual property, the agreement should address what happens to that intellectual property.

5. “Who Owns It?” Is Only the First Question

Ownership is important, but it is not the only issue. A CPG brand should also understand its practical rights to the information necessary to operate the business. That means asking:

Who owns the formula?

Was it created by the brand, acquired from someone else, developed jointly, or created by the manufacturer?

Who owns the manufacturing process?

Was the process provided by the brand, created by the co-manufacturer, or developed collaboratively during scale-up?

Who owns improvements?

If the manufacturer modifies the formula or production process to improve shelf life, reduce cost, increase yield, or solve a production problem, who owns that improvement?

What information must be provided to the brand?

Consider specifications, production records, Certificates of Analysis, testing results, quality records, ingredient information, and other documentation necessary to oversee the product and supply chain.

What information remains proprietary to the manufacturer?

A manufacturer may have pre-existing processes, equipment configurations, production methods, or general know-how that it uses across numerous customers. The agreement should distinguish that background know-how from brand-specific intellectual property.

What can the brand disclose to another manufacturer?

A brand may have access to certain information for quality or compliance purposes without having the right to deliver that information to a competing facility.

Does the brand have a license?

Sometimes ownership is not necessary if the brand receives a sufficiently broad, perpetual, transferable, or otherwise commercially useful license to the relevant technology.

What happens when the relationship ends?

Termination rights should be evaluated together with transition rights, inventory, tooling, documentation, assistance, and continued access to critical information.

6. Portability Is the Business Issue Behind the IP Question

For most CPG brands, this is not an academic intellectual-property exercise. It is a supply-chain issue. The practical question is: If this manufacturing relationship ends, can another qualified facility make the same product?

That may matter because of:

• pricing disputes;

• capacity limitations;

• quality problems;

• missed production schedules;

• retailer growth;

• geographic expansion;

• a co-manufacturer shutting down;

• an acquisition of the manufacturer;

• a financing or strategic transaction;

• a product recall; or

• a simple breakdown in the commercial relationship.

  
  

A brand that owns the formula but cannot replicate the product elsewhere may have significantly less manufacturing flexibility than it expected. That does not necessarily mean the brand must own every piece of manufacturing know-how, but it does mean the brand should understand the dependency and negotiate the relationship intentionally.

7. Think About Background IP and Newly Developed IP Separately

One useful way to structure these relationships is to distinguish between background IP and developed IP.

Background IP generally refers to intellectual property, methods, technology, know-how, or materials a party already owned or developed independently of the engagement.

For example, a co-manufacturer may have:

• proprietary processing techniques;

• standard production methods;

• equipment configurations;

• quality systems;

• software;

• testing procedures; or

• generalized manufacturing expertise.

  
  

A brand should not assume it acquires ownership of those assets merely because they are used to produce its product.

Developed IP is different and generally refers to refers to new intellectual property created, conceived, or discovered during the performance of the contract. If new intellectual property is created specifically during the engagement, the agreement should determine whether it is:

• owned by the brand;

• owned by the manufacturer;

• jointly owned;

• assigned to one party;

• licensed to the other party; or

• divided depending on the type of development.

  
  

Those decisions should reflect the economics of the relationship. If a brand specifically pays a manufacturer to develop a proprietary formulation or process that the brand expects to commercialize across multiple facilities, the contract should address that expectation. If the manufacturer is contributing valuable proprietary technology at its own expense, it may reasonably seek to retain ownership and limit the brand’s use.

The problem usually arises when neither side addresses the question until the relationship is ending.

8. Process Improvements Can Become a Hidden Ownership Problem

Development does not always happen at the beginning of the relationship. A product may evolve over years of manufacturing. The co-manufacturer may recommend:

• ingredient substitutions;

• new suppliers;

• manufacturing efficiencies;

• revised processing parameters;

• improved shelf-life techniques;

• packaging changes;

• revised testing methodologies; or

• other modifications.

  
  

Those changes may materially improve the product and the agreement should address whether those improvements belong to the brand, the manufacturer, or the party that created them. This issue becomes especially important when a product has changed significantly from the original version and the brand later wants to transition production elsewhere.

9. Confidentiality and Ownership Solve Different Problems

A strong confidentiality provision is important, but confidentiality is not a substitute for clear ownership and use rights. These concepts answer different questions.

Ownership asks who legally owns the intellectual property.

Confidentiality asks who may disclose the information.

Use restrictions ask what a party is permitted to do with the information.

Licensing determines whether one party may use intellectual property owned by another.

Transfer rights determine whether those rights or information can move to another manufacturer.

A contract can therefore provide the brand access to manufacturing information while still restricting the brand from disclosing it to another facility. Or, the manufacturer may retain ownership while granting the brand a broad license that effectively provides the portability the brand needs.

There is no single structure that fits every CPG relationship. The goal is to understand the commercial expectations and document them clearly.

10. Match the Agreement Structure to the Actual Relationship

Before production begins, CPG brands should identify what role the proposed manufacturing partner will actually play.

Pure manufacturing relationship

The brand provides the formula, process, and specifications. The co-manufacturer primarily provides production capacity. The focus is typically manufacturing performance, quality, supply, pricing, confidentiality, and protection of the brand’s existing IP.

Manufacturing plus scale-up

The brand owns the underlying formula but relies on the co-manufacturer to adapt the process for commercial production. The agreement should carefully address scale-up work, process improvements, manufacturing know-how, and portability.

Formulation or product development

The manufacturer or a separate developer is engaged to create or materially modify the product. A development or formulation agreement may be appropriate, with specific provisions covering development milestones, fees, ownership, assignments, licenses, and deliverables.

Private-label or manufacturer-owned product

The manufacturer may already own the formula and production process and allow the brand to sell the finished product under the brand’s own trademarks and packaging. In that structure, the brand should not assume it owns the underlying product IP merely because its name appears on the package.

These relationships can look similar on a retail shelf while creating very different legal and operational rights behind the scenes.

Practical Takeaways for CPG Brands

Before entering a co-manufacturing relationship, clarify:

• what intellectual property the brand already owns;

• what intellectual property the manufacturer already owns;

• whether formulation or development work is part of the engagement;

• who will own newly developed formulas, processes, and improvements;

• what production documentation the brand receives;

• what information is considered proprietary manufacturing know-how;

• what rights the brand has to use or disclose that information;

• whether the brand can transfer production to another facility;

• what transition assistance is required; and

• what happens to intellectual property rights after termination.

  
  

These issues are easier to negotiate before the parties have invested significant time, capital, and production resources into the relationship.

The Greenbar Approach: Contracting Around How the CPG Business Actually Operates

A good CPG manufacturing agreement should reflect more than a generic vendor relationship. The contract should account for how the product was developed, how it is actually manufactured, what each party contributes, where operational dependency exists, and what the brand needs to preserve continuity if the relationship changes.

Sometimes that means a straightforward co-manufacturing agreement. Sometimes it means a separate formulation or development agreement. Sometimes the right solution is a license rather than an assignment. What matters is that the contract structure matches the commercial reality.

At Greenbar, we approach CPG manufacturing, development, and other commercial agreements through that lens: identify the valuable assets, understand how the parties actually operate, allocate rights intentionally, and build a structure that protects the business without making the relationship unnecessarily difficult to manage.

Final Thought

You can own the brand. You can own the packaging. You can even own the formula. But before relying on a co-manufacturer, make sure you understand whether you also own—or have sufficient rights to—the process and know-how necessary to make the product somewhere else.

Know what you are buying. Know what you own. And know what you can take with you if the relationship ends.

Considering a co-manufacturing, formulation, or product-development agreement? Contact Greenbar to discuss how the relationship should be structured before production begins.